# ClinicalTrials.gov record NCT06073184

> PeptideScanner retained ClinicalTrials.gov record NCT06073184 at 2026-07-30T18:26:04.258Z. Its registry update date was 2025-06-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06073184-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-06-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06073184-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06073184-tirzepatide-v1.json
- Content SHA-256: `f5b0f1dab4ef7fc6d5289c588211e65a7950f3a2a086c14f7865367d05bba11b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06073184 ([`ctg-observation-nct06073184-2025-06-10-f1e2526395f8`](#source-ctg-observation-nct06073184-2025-06-10-f1e2526395f8))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06073184 at 2026-07-30T18:26:04.258Z. Its registry update date was 2025-06-10, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06073184-2025-06-10-f1e2526395f8`](#source-ctg-observation-nct06073184-2025-06-10-f1e2526395f8))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06073184 at 2026-07-30T18:26:04.258Z. Its registry update date was 2025-06-10, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06073184-2025-06-10-f1e2526395f8`](#source-ctg-observation-nct06073184-2025-06-10-f1e2526395f8))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06073184-2025-06-10-f1e2526395f8`](#source-ctg-observation-nct06073184-2025-06-10-f1e2526395f8))

## Sources

<a id="source-ctg-observation-nct06073184-2025-06-10-f1e2526395f8"></a>
- **ClinicalTrials.gov record NCT06073184 · retained source version 2025-06-10:f1e2526395f8049e2ac0ea81d322d7c4ac1d1f92858bed9c57ac756d8afe1bf2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06073184) (`ctg-observation-nct06073184-2025-06-10-f1e2526395f8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06073184." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06073184-tirzepatide-v1.json SHA-256: f5b0f1dab4ef7fc6d5289c588211e65a7950f3a2a086c14f7865367d05bba11b.